Results 251 to 260 of about 950,400 (402)
This study analyzes 148 patients (66 women and 82 men) with chronic myeloid leukemia treated with tyrosine kinase inhibitors, focusing on cardiovascular adverse events. The risk assessment, performed using the HFA/ICOS score, reveals sex‐specific differences: venous thrombosis is more common in women, while arterial thrombosis predominates in men.
Cristina Madaudo+10 more
wiley +1 more source
BCR::ABL1-Positive Acute Myeloid Leukemia. [PDF]
Canali A, Rieu JB, Lapierre L, Bain BJ.
europepmc +1 more source
Chronic myeloid leukemia associated with impairment of hearing. [PDF]
Christopher K. Williams, O. Ogan
openalex +1 more source
New anticancer therapies with potential cardiovascular side effects are continuously being introduced into clinical practice, with new and often unexpected toxicities becoming apparent only after clinical introduction. These unknown toxicities should be identified and understood beforehand to better prepare patients and physicians, enabling the ...
Alessandra Ghigo+22 more
wiley +1 more source
Bosutinib for Successful Treatment-Free Remission in Chronic Myeloid Leukemia. [PDF]
Fujioka Y+3 more
europepmc +1 more source
A monovalent cation-sensitive actin-binding factor in a myeloid leukemia cell line.
Kazuhiro Nagata+3 more
openalex +2 more sources
Myeloid hyperplasia in the SENCAR mouse: differentiation from granulocytic leukemia. [PDF]
Richard E. Long+2 more
openalex +1 more source
Cancer patients presenting to the emergency department ED with dyspnoea. Among 2153 patients presenting to the ED with dyspnea, 473 (22.0%) had an active or past cancer. Acute heart failure (AHF) was the most common final diagnosis in both groups. Pneumonia and cancer‐related dyspnoea were more common in cancer patients.
Paolo Bima+20 more
wiley +1 more source
Role of MicroRNAs in Acute Myeloid Leukemia. [PDF]
Wiśnik A+9 more
europepmc +1 more source
Monocytoid differentiation of freshly isolated human myeloid leukemia cells and HL-60 cells induced by the glutamine antagonist acivicin [PDF]
KE Nichols+3 more
openalex +1 more source